BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16477657)

  • 41. Accrual of Bone Mass in Children and Adolescents With Cystic Fibrosis.
    Sharma S; Jaksic M; Fenwick S; Byrnes C; Cundy T
    J Clin Endocrinol Metab; 2017 May; 102(5):1734-1739. PubMed ID: 28323913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
    Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
    Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cystic fibrosis-related diabetes in adults.
    Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Chung WY; Gibney J; O'Shea D
    Ir Med J; 2006 Mar; 99(3):83-6. PubMed ID: 16700261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
    Desmond CP; Wilson J; Bailey M; Clark D; Roberts SK
    Liver Int; 2007 Dec; 27(10):1402-8. PubMed ID: 18036103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development.
    Fustik S; Trajkovska M; Jakovska T; Spirevska L; Josifovska T; Koceva S
    Turk J Pediatr; 2008; 50(6):526-32. PubMed ID: 19227414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver disease as risk factor for cystic fibrosis-related diabetes development.
    Minicucci L; Lorini R; Giannattasio A; Colombo C; Iapichino L; Reali MF; Padoan R; Calevo MG; Casciaro R; De Alessandri A; Haupt R
    Acta Paediatr; 2007 May; 96(5):736-9. PubMed ID: 17381470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivity is a risk factor for low bone mineral density among haemophilic children.
    Tlacuilo-Parra A; Morales-Zambrano R; Tostado-Rabago N; Esparza-Flores MA; Lopez-Guido B; Orozco-Alcala J
    Br J Haematol; 2008 Mar; 140(5):562-7. PubMed ID: 18275434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis.
    Engelen MP; Com G; Deutz NE
    Clin Nutr; 2014 Dec; 33(6):1117-21. PubMed ID: 24423745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetic risk markers of low bone mineral density in cystic fibrosis children].
    Norek A; Sands D; Sobczyńska-Tomaszewska A; Chmielewski D; Szamotulska K; Czerska K; Bal J
    Med Wieku Rozwoj; 2010; 14(4):334-43. PubMed ID: 21462477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting clinical outcome in gastrostomy-fed children with cystic fibrosis.
    Oliver MR; Heine RG; Ng CH; Volders E; Olinsky A
    Pediatr Pulmonol; 2004 Apr; 37(4):324-9. PubMed ID: 15022129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis.
    McKeon D; Day A; Parmar J; Alexander G; Bilton D
    J Cyst Fibros; 2004 Aug; 3(3):193-5. PubMed ID: 15463908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
    Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
    Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents.
    Rovner AJ; Zemel BS; Leonard MB; Schall JI; Stallings VA
    J Pediatr; 2005 Sep; 147(3):327-31. PubMed ID: 16182670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anaesthesia for liver transplantation in cystic fibrosis patients.
    Della Rocca G; Pompei L; Pugliese F; Coccia C; Ruberto F; Montecchi C; Antonini M; Rossi M; Alfani D; Cortesini R; Gasparetto A
    Eur J Pediatr Surg; 1998 Oct; 8(5):278-81. PubMed ID: 9825237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone mineral content in infants and children with chronic cholestatic liver disease.
    Argao EA; Specker BL; Heubi JE
    Pediatrics; 1993 Jun; 91(6):1151-4. PubMed ID: 8502519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series.
    Linnane B; Oliver MR; Robinson PJ
    Arch Dis Child; 2006 Sep; 91(9):771-3. PubMed ID: 16737995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of lung inflammation on bone metabolism in adolescents with cystic fibrosis.
    Conway SP
    Paediatr Respir Rev; 2001 Dec; 2(4):324-31. PubMed ID: 12052304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low bone mineral density in young children with cystic fibrosis.
    Sermet-Gaudelus I; Souberbielle JC; Ruiz JC; Vrielynck S; Heuillon B; Azhar I; Cazenave A; Lawson-Body E; Chedevergne F; Lenoir G
    Am J Respir Crit Care Med; 2007 May; 175(9):951-7. PubMed ID: 17272788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural history of liver disease in cystic fibrosis.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1999 Nov; 30(5):1151-8. PubMed ID: 10534335
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of factors related to bone disease in Polish children and adolescents with cystic fibrosis.
    Sands D; Mielus M; Umławska W; Lipowicz A; Oralewska B; Walkowiak J
    Adv Med Sci; 2015 Sep; 60(2):315-20. PubMed ID: 26183540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.